Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer
Year: 2025
Type: article
Abstract: Collectively, sTIM-3 and sGal-9 may serve as novel non-invasive biomarkers for diagnosis and outcome prediction in patients with GC/GEJ.
Source: iScience
Authors: David Digomann, Charlotte Reiche, Antonia Stammberger, Tido Willms, Loreen S. Rudek, Anders Grabenkamp, Anna Klimova, Jamie Kölbel, Felix Merboth, Loreen Natusch Bufe, Carolin Beer, Therés Golle, Sarah Cronjaeger, Franziska Hoffmann, Luisa Kranich, Marc Schmitz, Christiane J. Bruns, Hans A. Schlößer, Jürgen Weitz, Lena Seifert, Adrian M. Seifert
Institutions: German Cancer Research Center, Helmholtz-Zentrum Dresden-Rossendorf, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, German Cancer Consortium (DKTK) Dresden, Technische Universität Dresden, University of Cologne, University Hospital Cologne, National Center for Tumor Diseases
Language: English
Topic: Galectins and Cancer Biology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,240
Awards: G1188163619, G5373097964, G8494782663
OpenAlex ID: W4416910383